Powered by: Motilal Oswal
2026-09-22 03:10:32 pm | Source: Accord Fintech
Syrma SGS climbs as its arm launches new Medical Plastics, Precision Molding plant in Jodhpur
Syrma SGS climbs as its arm launches new Medical Plastics, Precision Molding plant in Jodhpur

Syrma SGS Technology is currently trading at Rs. 1758.00, up by 45.15 points or 2.64% from its previous closing of Rs. 1712.85 on the BSE.

The scrip opened at Rs. 1725.00 and has touched a high and low of Rs. 1803.60 and Rs. 1708.65 respectively. So far 141132 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1,803.60 on 22-Sep-2026 and a 52 week low of Rs. 634.15 on 21-Jan-2026.

Last one week high and low of the scrip stood at Rs. 1,803.60 and Rs. 1420.00 respectively. The current market cap of the company is Rs. 34080.86 crore.

The promoters holding in the company stood at 42.28%, while Institutions and Non-Institutions held 23.43% and 34.29% respectively.

Syrma SGS Technology’s subsidiary -- Syrma Johari MedTech has launched its new Medical Plastics and Precision Molding Facility in Jodhpur, Rajasthan. With a plant area of more than 120,000 square feet, the Jodhpur facility brings together capabilities in medical plastics and precision molding, including injection molding, extrusion, blow molding and tooling. The facility is designed to support the manufacture of precision medical components, including multi-cavity and tight-tolerance molded components, medical and diagnostic tubing, customized tubing profiles and other specialized applications.

The Jodhpur facility further strengthens the broader manufacturing ecosystem of the Syrma SGS Group, with 17 global production sites and four design and innovation centres. Across the Group, these capabilities support customers through various stages of the product lifecycle, from design and engineering to manufacturing, tooling and assembly.

The new facility further strengthens Syrma Johari MedTech’s position as a design-led global MedTech CDMO, with capabilities spanning design and engineering, precision plastics, tooling, manufacturing, cleanroom operations and assembly. The company supports MedTech programmes across areas including diagnostics, medical aesthetics, patient monitoring, surgical and interventional care, critical care, rehabilitation and physical therapy.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here